Physician profile
Jonathan E Velasco
NPI 1962477661
$2,397.76
in general payments reported to CMS, 2019-2025
15 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $776 · 2021: $681 · 2022: $17.26 · 2023: $503 · 2024: $305 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $476.88 | 2019-2023 | |
| Endologix LLC | $340.07 | 2019 | |
| Silk Road Medical, INC. | $318.02 | 2021 | |
| W. L. Gore & Associates, INC. | $311.68 | 2021-2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Vbx Balloon Expandable Endo |
| Abbott Laboratories | $173.66 | 2023 | Xact |
| Medtronic, INC. | $169.25 | 2024 | Heli-Fx Endoanchor System |
| Shockwave Medical, INC | $147.92 | 2021 | |
| Angiodynamics, INC. | $136.12 | 2024 | Angiovac |
| Bard Peripheral Vascular, INC. | $118.42 | 2021 | |
| Janssen Pharmaceuticals, INC | $79.72 | 2019 | |
| Cook Medical LLC | $53.06 | 2021 | |
| Organogenesis INC. | $26.47 | 2023 | Puraply |
| Baxter Healthcare | $17.26 | 2022 | |
| Cardiovascular Systems INC. | $16.18 | 2021 | |
| Lemaitre Vascular, INC. | $13.05 | 2023 | Trivex System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Velasco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.